PRLR and acute myeloid leukemia: In concordance, the presence of elimusertib, an ATR inhibitor, increased the sensitivity to PRLR-overexpressing AML cells to cytarabine treatment, as compared to the parental cell line (Fig. 6E), suggesting that ATR played a key role in the chemoresistance observed upon enforced expression of PRLR wt.